SHOWCASE: Marketing: Meeting Customers Where They Are: Marketing 3.0

Today, pharmaceutical marketers are under pressure to assess the channels and methods they have traditionally used to engage with customers in response to the changing behaviors and expectations of physicians, payers, and consumers. That could take a shift in thinking for the industry, since desp...

By PharmaVoice Team • Sept. 1, 2018

Is There Room for the Greater Good in Healthcare Marketing?

There was a time when the job of PR departments was either pushing out positive news of a company’s good deeds or reacting to bad news. Over the last two decades, with ever-increasing levels of digitally enabled transparency, this dynamic has shifted. Organizations need to practice what they prea...

By Andrew Schirmer • Sept. 1, 2018

Trying to Reach Healthcare Professionals and Consumers? Social Media Is the Answer.

Social media is a powerful platform for reaching HCPs and consumers alike. There are nearly 200 million active social media users in the United States alone, so it’s almost guaranteed that your target audience is using social channels, consuming content about anything and everything. So why not t...

By Brandie Linfante • Sept. 1, 2018

No Brakes: Picking the Partner to Speed Oncology and Rare Disease Candidates to Market

Imagine a company created with an end goal of delivering lifesaving therapies to patients faster while mitigating risks, minimizing obstacles, and maximizing time on market. Sounds like a turbocharged unicorn, right? Enter Precision Medicine Group (PMG)—built with a laser focus on quality and exp...

By Carolyn Morgan • Sept. 1, 2018

Access now➔

Trendline

Increasing diversity in clinical trials

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.